alprenolol has been researched along with Akinetic-Rigid Variant of Huntington Disease in 1 studies
Alprenolol: One of the ADRENERGIC BETA-ANTAGONISTS used as an antihypertensive, anti-anginal, and anti-arrhythmic agent.
alprenolol : A secondary alcohol that is propan-2-ol substituted by a 2-allylphenoxy group at position 1 and an isopropylamino group at position 3. It is a beta-adrenergic antagonist used as a antihypertensive, anti-arrhythmia and a sympatholytic agent.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Enna, SJ | 1 |
| Bird, ED | 1 |
| Bennett, JP | 1 |
| Bylund, DB | 1 |
| Yamamura, HI | 1 |
| Iversen, LL | 1 |
| Snyder, SH | 1 |
1 other study available for alprenolol and Akinetic-Rigid Variant of Huntington Disease
| Article | Year |
|---|---|
Huntington's chorea. Changes in neurotransmitter receptors in the brain.
Topics: Alprenolol; Binding Sites; Binding, Competitive; Brain; Caudate Nucleus; Cerebral Cortex; Choline O- | 1976 |